Literature DB >> 30243797

Characterization of T cell immunophenotypes in intestinal transplantation: A pilot study.

Marjorie-Anne R Guerra1, Maura Rossetti2, Zhenyu Zhang3, Xinkai Zhou4, Emily C Whang5, Robert S Venick6, Elizabeth A Marcus7, Suzanne V McDiarmid6, Douglas G Farmer8, Elaine F Reed2, Laura J Wozniak5.   

Abstract

Immunophenotyping of peripheral blood mononuclear cells has been shown to be a useful, non-invasive method of predicting acute cellular rejection (ACR) following intestinal transplantation (ITx). Our objectives were to characterize differences in the T cell immunophenotype of ITx recipients in peripheral blood samples (1) collected late versus early after ITx and (1) associated with episodes of ACR and infectious enteritis. An IRB-approved, cross-sectional study of ITx recipients was performed. Peripheral blood samples were collected during normal visits and episodes of allograft dysfunction. A total of 38 patients were included in the analysis: 31 ITx recipients (87% liver-inclusive allografts) and 7 intestinal failure control patients. Of the ITx patients, 26 patients were pediatric patients (<21 years). A total of 70 samples were analyzed from ITx recipients, including 51 during normal visits and 19 during episodes of allograft dysfunction (median of 2 samples per patient; range of 1-6 samples per patient). In the late (n = 32) versus early post-ITx (n = 19) normal samples, there was a significantly higher percentage of central memory CD4 T cells (p = .001). In the ACR (n = 5) versus infectious enteritis (n = 14) samples, there was a higher percentage of CD8 T cells expressing HLA-DR (p = .002), CD57 (p < .001), and KLRG1 (p < .001) and a higher percentage of CD4 T cells expressing CD57 (p = .03). Additional studies are needed with larger cohorts to validate these changes in the T cell immunophenotype. Further elucidating T cell immunophenotypes in ITx will lead to a better understanding of immune mechanisms of allograft dysfunction, identification of potential biomarkers in ITx, and optimized selection of immunosuppressive therapies.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immune monitoring; Immunophenotyping; Infection; Intestinal transplantation; Rejection; T cell

Mesh:

Substances:

Year:  2018        PMID: 30243797      PMCID: PMC6579529          DOI: 10.1016/j.trim.2018.09.003

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  40 in total

1.  Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium.

Authors:  P Ruiz; A Bagni; R Brown; G Cortina; N Harpaz; M S Magid; J Reyes
Journal:  Transplant Proc       Date:  2004-03       Impact factor: 1.066

2.  What's new--what's hot in basic science: American Transplant Congress 2004.

Authors:  Allan D Kirk
Journal:  Am J Transplant       Date:  2004-11       Impact factor: 8.086

Review 3.  Intestinal transplantation.

Authors:  Thomas M Fishbein
Journal:  N Engl J Med       Date:  2009-09-03       Impact factor: 91.245

4.  Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal transplantation.

Authors:  Andre I David; Gennaro Selvaggi; Phillip Ruiz; Jeffrey J Gaynor; Panagiotis Tryphonopoulos; Gary I Kleiner; Jang I Moon; Seigo Nishida; Peter A Pappas; Lobella Conanan; Debbie Weppler; Violet Esquenazi; David M Levi; Tomoaki Kato; Andreas G Tzakis
Journal:  Transplantation       Date:  2007-11-15       Impact factor: 4.939

Review 5.  Memory T-cell-specific therapeutics in organ transplantation.

Authors:  Andrew J Page; Mandy L Ford; Allan D Kirk
Journal:  Curr Opin Organ Transplant       Date:  2009-12       Impact factor: 2.640

6.  Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation.

Authors:  Chethan Ashokkumar; Ankit Gupta; Qing Sun; Mylarappa B Ningappa; Brandon W Higgs; George Mazariegos; Tamara Fazzolare; Lisa Remaley; Kyle Soltys; Geoffrey Bond; Kareem Abu-Elmagd; Rakesh Sindhi
Journal:  Surgery       Date:  2009-06-26       Impact factor: 3.982

7.  Fecal calprotectin level measurements in small bowel allograft monitoring: a pilot study.

Authors:  Edip Akpinar; Jacinto Vargas; Tomaoki Kato; Lesley Smith; Erick Hernandez; Gennaro Selvaggi; Seigo Nishida; Jang Moon; Eddie Island; David Levi; Philip Ruiz; Andreas G Tzakis
Journal:  Transplantation       Date:  2008-05-15       Impact factor: 4.939

8.  Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients.

Authors:  Fabien Stenard; Christine Nguyen; Ken Cox; Neeraja Kambham; Dale T Umetsu; Sheri M Krams; Carlos O Esquivel; Olivia M Martinez
Journal:  Pediatr Transplant       Date:  2008-03-10

9.  Cost-effectiveness of upper gastrointestinal endoscopy according to the appropriateness of the indication.

Authors:  Emilio Di Giulio; Cesare Hassan; Perry J Pickhardt; Angelo Zullo; Andrea Laghi; David H Kim; Franco Iafrate
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

10.  Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation.

Authors:  C Ashokkumar; A Talukdar; Q Sun; B W Higgs; J Janosky; P Wilson; G Mazariegos; R Jaffe; A Demetris; J Dobberstein; K Soltys; G Bond; A W Thomson; A Zeevi; R Sindhi
Journal:  Am J Transplant       Date:  2008-10-31       Impact factor: 8.086

View more
  2 in total

1.  T cell reconstitution after lymphocyte depletion features a different pattern of inhibitory receptor expression in ABO- versus HLA-incompatible kidney transplant recipients.

Authors:  A Del Bello; N Kamar; E Treiner
Journal:  Clin Exp Immunol       Date:  2020-01-23       Impact factor: 4.330

2.  Non-HLA AT1R antibodies are highly prevalent after pediatric intestinal transplantation.

Authors:  Alvin P Chan; Marjorie-Anne R Guerra; Maura Rossetti; Michelle J Hickey; Robert S Venick; Elizabeth A Marcus; Suzanne V McDiarmid; Douglas G Farmer; Elaine F Reed; Laura J Wozniak
Journal:  Pediatr Transplant       Date:  2021-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.